Effects of FK-506 on the course of murine salmonellosis

Journal of Chemotherapy

Volumn 8, Issue 6, 1996, Pages 449-456

  Nichterlein, T ^a  

^a Institute of Medical Microbiology   (Germany)

Author keywords

cyclosporin A; FK 506; immunosuppression; murine salmonellosis; Salmonella typhimurium

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; CELL PROLIFERATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPLEEN CELL; T LYMPHOCYTE;

EID: 0030449412     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.6.449     Document Type: Article

References (19)

1. Fung JJ, Thomson AW, Pinna A, Selby RR, Starzl TE. State of immunosuppressive agents in organ transplantation. Transplant Proc 1992; 24: 2372-2374.
2. Morris PJ. Cyclosporine, FK506 and other drugs in organ transplantation. Curr Opin Immunol 1991; 3: 748-751.
3. Williams P. Immunosuppressive drugs. New therapeutic applications. ASM News 1993; 59: 76-78.
4. White D. Immunosuppression. In: Brosthoff J, Scadding GK, Male DK, Roitt IM eds. Clinical Microbiology. London: Gower Medical Publishing 1991; 27.1 - 27.10.
5. Thomas J, Matthews C, Carroll R, Loreth R, Thomas F. The immunosuppressive action of FK506. Transplantation 1990; 49: 390-396.
6. Valdivia LA, Fung JJ, Demetris AJ, Starzl TE. Differential survival of hamster-to-rat liver and cardiac xenografts under FK506 immunosuppression. Transplant Proc 1991; 23: 3269-3271.
7. Alessiani M, Kusne S, Martin M, et al. Infections in adult liver transplant patients under FK506 immunosuppression. Transplant Proc 1991; 1: 1501-1503.
8. Uemoto S, Tanaka K, Fujita S, et al. Infectious complications in living related liver transplantation. J Pediatr Surg 1994; 29: 514-517.
9. Strauss R, Heymer B, Hof H. Effects of cyclosporin A on experimental infection with Listeria monocytogenes. Clin Exp Immunol 1985; 62: 491-498.
10. Hof H, Strauss R. Suppression of acquired immunity to infection with Salmonella typhimurium by cyclosporin A. Curr Microbiol 1986; 13: 177-178.
11. Ziprin RL. Salmonella. In: Hui YH, Gorham JR, Murrell KD, Cliver DO, eds. Foodborne disease handbook. New York: Marcel Dekker 1994; 253-318.
12. Hsu HS. Pathogenesis and immunity in murine salmonellosis. Microbiol Rev 1989; 53:390-409.
13. Dunlap NE, Benjamin WH, Briles DE. The intracellular nature of salmonella infection during the early stages of mouse typhoid. In: Zwilling BS, Eisenstein TK. Macrophage-pathogen interactions. New York: Marcel Dekker 1994: 303-312.
14. + cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection. J Immunol 1990; 145: 1265-1269.
15. Hormaeche CE, Mastroeni P, Arena A, Uddin J, Joysey HS. T cells do not mediate the initial suppression of a salmonella infection in the RES. Immunol 1990; 70: 247-250.
16. Muotiala A, Mäkelä H. Role of gamma-interferon in late stages of murine salmonellosis. Infect Immun 1993; 61: 4248-4253.
17. Mastroeni P, Villarreal-Ramos B, Hormaeche CE. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/C mice requires both immune serum and T cells. Infect Immun 1993; 61: 3981-3984.
18. Bishop DK, Li W. Cyclosporin A and FK506 mediate differential effects on T-cell activation in vivo. J Immunol 1992; 148: 1049-1054.
19. + T-cell function in vivo. Transplant Proc 1991; 23: 2945-2947.